Femme Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The biological response to treatment with tamoxifen in the preoperative situation is studying in this protocol. This study will enrolls patients with non-metastatic breast cancer HR +. The relationship between the CYP2D6 polymorphism, pharmacokinetics and biological efficacy of TAM will be studied.
Critère d'inclusion
- Non-Metastatic Breast Cancer